About Enhancer
| Enhancer ID: | E_02_0027 |
| Species: | human |
| Position : | chr19:15232268-15234268   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Cutaneous t-cell lymphoma |
| Pubmed ID: | 29180399 |
| Enhancer experiment: | RT-PCR,ChIP,Transfection |
| Enhancer experiment description: | We therefore describe a novel oncogenic pathway featuring IL-15, miR-29b, and BRD4 in CTCL, and suggest targeting of these components as a potentially effective therapy for CTCL patients. |
About Target gene
| Target gene : | BRD4 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | We therefore describe a novel oncogenic pathway featuring IL-15, miR-29b, and BRD4 in CTCL, and suggest targeting of these components as a potentially effective therapy for CTCL patients. |
About TF
| TF name : | -- |
| TF experiment: | RT-PCR,ChIP,Transfection |
| TF experiment description: | We therefore describe a novel oncogenic pathway featuring IL-15, miR-29b, and BRD4 in CTCL, and suggest targeting of these components as a potentially effective therapy for CTCL patients. |
About Function
| Enhancer function : | We therefore describe a novel oncogenic pathway featuring IL-15, miR-29b, and BRD4 in CTCL, and suggest targeting of these components as a potentially effective therapy for CTCL patients. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
We therefore describe a novel oncogenic pathway featuring IL-15, miR-29b, and BRD4 in CTCL, and suggest targeting of these components as a potentially effective therapy for CTCL patients. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene